Analysis of an anti-B lymphocyte stimulator monoclonal antibody B7 and its binding activity to myeloma and lymphoma cell lines

Hybridoma

Volumn 25, Issue 4, 2006, Pages 238-242

  Sun, Jian ^a,b   Li, Yan ^b   Yu, Ming ^b   Sun, Yingxun ^b   Feng, Jiannan ^b   Shen, Beifen ^b  

^a TIANJIN UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE STIMULATING FACTOR; CYTOKINE; IMMUNOGLOBULIN G3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B7; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER CELL; CELL STRAIN SKO 007; CELL STRAIN U937; CELL STRAIN XG 7; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DAUDI CELL; DOSE RESPONSE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOMA; LYMPHOMA CELL LINE; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROGNOSIS; RAJI CELL;

EID: 33750993177     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2006.25.238     Document Type: Article

References (23)

1. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, and Hilbert DM: BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999;286:260-263.
2. Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, and Tschopp J: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999;189:1747-1756.
3. Shu HB, Hu WH, and Johnson H: TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 1999;65:680-683.
4. Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, Browning JL, and Mackay F: BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000;192:1453-1465.
5. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, and Scott ML: An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001;293:2111-2114.
6. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, and Clegg CH: TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000;404:995-999.
7. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, and Ambrose C: BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001;293:2108-2111.
8. Claudio E, Brown K, Park S, Wang H, and Siebenlist U: BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 2002;3:958-965.
9. Shu H and Johnson H: B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. Proc Natl Acad Sci USA 2000;97:9156-9161.
10. O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, and Noelle RJ: BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004;199:91-98.
11. Claudio JO, Masih-Khan E, Tang H, Gonáalves J, Voralia M, Li ZH, Nadeem V, Cukerman E, Francisco-Pobalan O, Liew CC, Woodgett JR, and Stewart AK: A molecular compendium of genes expressed in multiple myeloma. Blood 2002;100:2175-2186.
12. He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, and Cerutti A: Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 2004;172:3268-3279.
13. Novak AJ, Darce JR, Arendt BK, Harder B, Henderson K, Kindsvogel W, Gross JA, Greipp PR, and Jelinek DF: Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 2004;103:689-694.
14. Moreaux J, Legouffe E, Jourdan E, Quittet P, Räme T, Lugagne C, Moine P, Rossi JF, Klein B, and Tarte K: BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004;103:3148-3157.
15. Briones J, Timmerman JM, Hubert DM, and Levy R: BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp Haematol 2002;30:135-141.
16. Novak AJ, Bram RJ, Kay NE, and Jelinek DF: Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 2002;100:2973-2979.
17. Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin PV, Feldblum S, and Kolb JP: Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004;103:679-688.
18. Sun J, Li Y, Sun Y, Yu M, Feng J, and Shen B: Preparation and characterization of a monoclonal antibody against human B lymphocyte stimulator. Hybridoma (Larchmt) 2006;25:80-85.
19. Xie Z, Quo N, Yu M, Hu M, and Shen B: A new format of bispecific antibody: highly efficient heterodimerization, expression and tumor cell lysis. J Immunol Methods 2005;296:95-101.
20. Rahman ZSM, Rao SP, Susan L, Kalled SL, and Manser T: Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med 2003;198:1157-1169.
21. Khare SD, Sarosi I, Xia XZ, McCabe S, Miner K, Solovyev I, Hawkins N, Kelley M, Chang D, Van G, Ross L, Delaney J, Wang L, Lacey D, Boyle WJ, and Hsu H: Severe B cell hyperplasia and autoimmune diseases in TALL-1 transgenic mice. Proc Natl Acad Sci USA 2000;97:3370-3375.
22. Hahne M, Kataoka T, Schruter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D, and Tschopp J: APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998;188:1185-1190.
23. Patel DR, Wallweber HJA, Yin JP, Shriver SK, Marsters SA, Gordon NC, Starovasnik MA, and Kelley RF: Engineering an APRIL-specific B cell maturation antigen. J Biol Chem 2004;279:16727-16735.